| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (groß) | News + Adhoc | Bilanz/GuV | Termine | Zertifikate | Depot |
| Times + Sales | Chart-Analyse | Analysen | Dividende/HV | Profil | Optionsscheine | Watchlist |
| Börsenplätze | Chartvergleich | Kursziele | Vergleich | Insidertrades | Knock-outs | myHome |
| Orderbuch | Realtime Stuttgart | RSS Feed | Analyse | im Forum | Fonds | Senden |
| Historisch | Realtime Push | myNews neu | Ausblick | IR-Daten | Anleihen | handeln |
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 3 | 1 | 1 | 60,00 $ | -0,86% |
| Alexion Pharmaceuticals Inc. | 5 | 1 | 0 | 92,60 $ | +5,71% |
| Allergan Inc. | 4 | 0 | 0 | 101,25 $ | +14,94% |
| AstraZeneca plc | 2 | 4 | 5 | 28,19 £ | +8,76% |
| Bayer | 15 | 12 | 0 | 61,22 € | +25,40% |
| Celgene Corp. | 8 | 1 | 0 | 82,71 $ | +26,60% |
| Evotec AG | 3 | 0 | 0 | 3,75 € | +90,36% |
| Gilead Sciences Inc. | 9 | 1 | 0 | 59,56 $ | +22,38% |
| GlaxoSmithKline plc (GSK) | 5 | 8 | 1 | 15,31 £ | +8,20% |
| Merck Co. | 2 | 3 | 0 | 38,50 $ | +3,55% |
| Merck KGaA | 4 | 17 | 1 | 81,56 € | +9,80% |
| Mylan Inc | 3 | 0 | 0 | 27,00 $ | +28,69% |
| Novartis AG | 10 | 8 | 1 | 56,60 | +13,27% |
| Pfizer Inc. | 7 | 4 | 1 | 23,75 $ | +9,75% |
| Roche Holding AG (Genussschein) | 0 | 0 | 0 | - | - |
| Roche Holding AG (Inhaberaktie) | 10 | 5 | 0 | 169,00 | +6,29% |
| Sanofi S.A. | 13 | 8 | 2 | 58,61 € | +9,53% |
| STADA Arzneimittel AG (vink. NA) | 9 | 10 | 1 | 25,99 € | +14,59% |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 5 | 2 | 0 | 54,33 $ | +39,27% |
| Vertex Pharmaceuticals Inc. | 4 | 3 | 0 | 50,43 $ | -15,33% |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |